Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:57 PM
Ignite Modification Date:
2025-12-24 @ 10:57 PM
NCT ID:
NCT02403869
Eligibility Criteria:
Inclusion Criteria:
* Patients who give their written informed consent.
* Patients with metastatic breast cancer who start treatment with second-line monochemotherapy.
* Patients of both sexes, at least 18 years of age and of any race.
* Patients with life expectancy longer than or equal to 12 weeks.
* Patients with histological or cytological diagnosis of Her-2/neu negative breast adenocarcinoma.
* Patients with ability enough to understand the questionnaires.
Exclusion Criteria:
* Pregnant or lactating women.
* Patients who have been treated with chemotherapy in the last three weeks
* Patients who refuse to participate in the study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02403869
Study Brief:
Protocol Section:
NCT02403869